Back to CELG-RI
KBC Group NV CELG-RI Position History
Bristol-Myers Squibb Company Ce • Healthcare
Quarters held
15
Latest value
$4.4M
Q3 2026
Peak value
$257.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.1M |
| Q3 2025 | $178.5M |
| Q3 2025 | $4M |
| Q4 2025 | $1.3M |
| Q4 2025 | $208M |
| Q4 2025 | $4.7M |
| Q1 2026 | $1.5M |
| Q1 2026 | $236.5M |
| Q1 2026 | $5.2M |
| Q2 2026 | $1.4M |
| Q2 2026 | $240.4M |
| Q2 2026 | $3.9M |
| Q3 2026 | $1.5M |
| Q3 2026 | $257.9M |
| Q3 2026 | $4.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.4M | 70.1K | — | — |
| Q3 2026 | $257.9M | 4.13M | — | — |
| Q3 2026 | $1.5M | 24.6K | — | — |
| Q2 2026 | $3.9M | 66.9K | — | — |
| Q2 2026 | $240.4M | 4.17M | — | — |
| Q2 2026 | $1.4M | 24.6K | — | — |
| Q1 2026 | $5.2M | 84.9K | — | — |
| Q1 2026 | $236.5M | 3.90M | — | — |
| Q1 2026 | $1.5M | 24.6K | — | — |
| Q4 2025 | $4.7M | 86.5K | — | — |
| Q4 2025 | $208M | 3.86M | — | — |
| Q4 2025 | $1.3M | 24.6K | — | — |
| Q3 2025 | $4M | 88.3K | — | — |
| Q3 2025 | $178.5M | 3.96M | — | — |
| Q3 2025 | $1.1M | 24.6K | — | — |
Other funds holding CELG-RI
$11.1B
$9.6B
$8.5B
$7.9B
$5.9B
$5.9B
$5.8B